Gene Delivery Revolution: Exploring the Latest Advances in AAV, Lentivirus, and Adenovirus Vectors
The field of gene therapy is undergoing a transformative revolution, driven by remarkable advancements in viral vector technology. Among the leading tools in this arena are Adeno-Associated Virus (AAV), Lentivirus, and Adenovirus vectors, each offering unique advantages for gene delivery. These vectors have unlocked new possibilities in treating genetic disorders, enabling precise, efficient, and safe gene transfer to target cells.
This session delves into the latest innovations and applications of these viral vectors, shedding light on how they are shaping the future of medicine — from improved targeting capabilities to enhanced scalability.
Speaker
Heidi Chu
Product Marketing Manager | Applied Biological Materials (abm)
Heidi Chu is the Product Marketing Manager at Applied Biological Materials, with a joint degree in Business and Molecular Biology from BCIT and the University of British Columbia. With over 8 years of experience, she has deep expertise in viral vectors — from packaging and production to advanced applications in cell engineering, including cell immortalization — and played a key role in establishing high-titer AAV purification methods at abm.
Key Learning Objectives
- Emerging technologies in gene delivery: latest advancements in AAV, Lentivirus and Adenovirus vector design and production
- Cutting-edge tools to enhance efficiency, targeting and therapeutic potential
- Applications in gene therapy, cell therapy and vaccine development, in preclinical and clinical research
- Overcoming challenges: scalability, manufacturing bottlenecks and regulatory hurdles
- Optimizing transduction efficiency and minimizing off-target effects
Watch Now: Gene Delivery Revolution: Exploring the Latest Advances in AAV, Lentivirus, and Adenovirus Vectors
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- December 17, 2024 · 11:00 AM – 12:00 PM IST
- Heidi Chu, Applied Biological Materials (abm)
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and you'll go straight to the recording — we'll also email you the link.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar